EP2410043A3 - Stammzellenkultursysteme - Google Patents

Stammzellenkultursysteme Download PDF

Info

Publication number
EP2410043A3
EP2410043A3 EP20110174157 EP11174157A EP2410043A3 EP 2410043 A3 EP2410043 A3 EP 2410043A3 EP 20110174157 EP20110174157 EP 20110174157 EP 11174157 A EP11174157 A EP 11174157A EP 2410043 A3 EP2410043 A3 EP 2410043A3
Authority
EP
European Patent Office
Prior art keywords
cultures
stem cells
cells
culture systems
cells culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20110174157
Other languages
English (en)
French (fr)
Other versions
EP2410043A2 (de
Inventor
Etti Ben Shushan
Shelly Tannenbaum
Pavel Itsykson
Eyal Banin
Benjamin Reubinoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hadasit Medical Research Services and Development Co
Original Assignee
Hadasit Medical Research Services and Development Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Medical Research Services and Development Co filed Critical Hadasit Medical Research Services and Development Co
Publication of EP2410043A2 publication Critical patent/EP2410043A2/de
Publication of EP2410043A3 publication Critical patent/EP2410043A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/44—Thiols, e.g. mercaptoethanol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/98—Xeno-free medium and culture conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
EP20110174157 2004-12-29 2005-12-29 Stammzellenkultursysteme Withdrawn EP2410043A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63980904P 2004-12-29 2004-12-29
EP05821535.1A EP1844136B1 (de) 2004-12-29 2005-12-29 Stammzellenkultursysteme

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
EP05821535.1A Division-Into EP1844136B1 (de) 2004-12-29 2005-12-29 Stammzellenkultursysteme
EP05821535.1 Division 2005-12-29

Publications (2)

Publication Number Publication Date
EP2410043A2 EP2410043A2 (de) 2012-01-25
EP2410043A3 true EP2410043A3 (de) 2013-01-23

Family

ID=36615324

Family Applications (3)

Application Number Title Priority Date Filing Date
EP20110174157 Withdrawn EP2410043A3 (de) 2004-12-29 2005-12-29 Stammzellenkultursysteme
EP11174158.3A Active EP2410044B1 (de) 2004-12-29 2005-12-29 Stammzellenkultursysteme
EP05821535.1A Active EP1844136B1 (de) 2004-12-29 2005-12-29 Stammzellenkultursysteme

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP11174158.3A Active EP2410044B1 (de) 2004-12-29 2005-12-29 Stammzellenkultursysteme
EP05821535.1A Active EP1844136B1 (de) 2004-12-29 2005-12-29 Stammzellenkultursysteme

Country Status (4)

Country Link
US (2) US20090104695A1 (de)
EP (3) EP2410043A3 (de)
ES (1) ES2525684T3 (de)
WO (1) WO2006070370A2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247459B1 (en) 1998-10-19 2007-07-24 Ajinomoto Co., Inc. L-glutamic acid producing bacterium and process for producing L-glutamic acid
US7410798B2 (en) 2001-01-10 2008-08-12 Geron Corporation Culture system for rapid expansion of human embryonic stem cells
CN100549163C (zh) 2002-12-16 2009-10-14 技术研究及发展基金有限公司 制备无饲养细胞、无异源的人胚胎干细胞的方法以及使用该方法制备的干细胞培养物
ES2415358T3 (es) 2004-04-21 2013-07-25 The Brigham And Women's Hospital, Inc. Péptidos de fijación a la poli-N-acetil glucosamina (PNAG/DPNAG) y procedimientos para el uso de los mismos
US8597947B2 (en) 2004-12-29 2013-12-03 Hadasit Medical Research Services & Development Limited Undifferentiated stem cell culture systems
WO2006070370A2 (en) 2004-12-29 2006-07-06 Hadasit Medical Research Services & Development Limited Stem cells culture systems
KR20160116024A (ko) 2005-06-22 2016-10-06 아스테리아스 바이오세라퓨틱스, 인크. 인간 배아 줄기 세포의 현탁 배양
FI20055398A0 (fi) 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Menetelmä solupopulaatioiden evaluoimiseksi
AU2015203310B2 (en) * 2005-08-29 2017-04-20 Technion Research & Development Foundation Ltd. Media for Culturing Stem Cells
AU2006286149B2 (en) 2005-08-29 2012-09-13 Technion Research And Development Foundation Ltd. Media for culturing stem cells
US9040297B2 (en) 2006-08-02 2015-05-26 Technion Research & Development Foundation Limited Methods of expanding embryonic stem cells in a suspension culture
WO2008040532A1 (en) * 2006-10-02 2008-04-10 Cellartis Ab Novel toxicity assay based on human blastocyst-derived stem cells and progenitor cells
EP3640326A1 (de) 2007-04-18 2020-04-22 Hadasit Medical Research Services & Development Limited Aus stammzellen erhaltene retinale pigmentepithelzellen
WO2009132156A1 (en) * 2008-04-22 2009-10-29 Regenerative Research Foundation Retinal pigment epithelial stem cells
WO2010083203A2 (en) * 2009-01-13 2010-07-22 StemBios Technologies, Inc. Non-embryonic stem cells and uses thereof
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
ES2932664T3 (es) 2009-11-12 2023-01-23 Technion Res & Dev Foundation Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en estado no diferenciado
KR102073730B1 (ko) 2009-11-17 2020-02-05 아스텔라스 인스티튜트 포 리제너러티브 메디슨 인간 ｒｐｅ 세포의 생산 방법 및 인간 ｒｐｅ 세포의 제약 제제
ES2725549T3 (es) 2010-07-12 2019-09-24 Univ Southern California Sustrato biocompatible para facilitar las interconexiones entre células madre y tejidos diana y métodos para implantarlo
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
US20140178894A1 (en) * 2011-04-20 2014-06-26 Novartis Forschungsstiftung, Zweigniederlassung Culture medium suitable for the culture of undifferentiated cells
US8877489B2 (en) 2011-12-05 2014-11-04 California Institute Of Technology Ultrathin parylene-C semipermeable membranes for biomedical applications
US10478206B2 (en) 2011-04-29 2019-11-19 University Of Southern California Instruments and methods for the implantation of cell-seeded substrates
TWI571513B (zh) 2011-09-28 2017-02-21 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
EP3243903A1 (de) 2012-02-14 2017-11-15 Washington State University Feeder-freies verfahren zur kultivierung von spermatogonienstammzellen von rindern und schweinen
CN103627669A (zh) * 2012-08-22 2014-03-12 复旦大学 一种诱导人多能干细胞分化为视网膜前体细胞的方法
TWI687519B (zh) 2012-12-06 2020-03-11 美商幹細胞生物科技股份有限公司 Ｌｇｒ５＋體幹細胞
EP2746770A1 (de) 2012-12-21 2014-06-25 Stembios Technologies, Inc. Verfahren zur Beurteilung der Wirkung einer Aktion basierend auf Stammzelldynamik auf eine Person
EP3919505B1 (de) 2013-01-16 2023-08-30 Emory University Verwendungen von cas9-nukleinsäurekomplexen
WO2014162040A1 (en) * 2013-04-03 2014-10-09 Tampereen Yliopisto Methods and media for differentiating eye cells
US10066241B2 (en) 2014-05-30 2018-09-04 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods of delivering treatments for latent viral infections
JP6421374B2 (ja) * 2014-09-30 2018-11-14 株式会社ジェイテックコーポレーション 万能性幹細胞の培養方法
WO2016081553A1 (en) * 2014-11-19 2016-05-26 StemBios Technologies, Inc. Somatic stem cells for treating bone defects
AU2015373050B2 (en) 2014-12-30 2022-09-29 Cell Cure Neurosciences Ltd. RPE cell populations and methods of generating same
CA2972580A1 (en) 2014-12-30 2016-07-07 Cell Cure Neurosciences Ltd. Assessing retinal pigment epithelial cell populations
WO2016159177A1 (ja) * 2015-03-30 2016-10-06 味の素株式会社 キレート化鉄を含む神経幹細胞用培地
US10117911B2 (en) 2015-05-29 2018-11-06 Agenovir Corporation Compositions and methods to treat herpes simplex virus infections
ES2865024T3 (es) 2015-07-29 2021-10-14 Hadasit Med Res Service Producción a gran escala de células de epitelio pigmentario retiniano
AU2016303631B2 (en) 2015-08-05 2022-07-28 Cell Cure Neurosciences Ltd. Preparation of photoreceptors for the treatment of retinal diseases
PL3331994T3 (pl) 2015-08-05 2023-01-30 Cell Cure Neurosciences Ltd. Wytwarzanie komórek nabłonka barwnikowego siatkówki
EP3595687A1 (de) 2017-03-16 2020-01-22 Lineage Cell Therapeutics, Inc. Verfahren zur messung der therapeutischen wirkung von therapien bei retinalen krankheiten
EP3731789A4 (de) 2017-12-29 2021-09-08 Cell Cure Neurosciences Ltd. Retinale pigmentepithelzeltzusammensetzungen
EP4351334A1 (de) 2021-06-09 2024-04-17 Lineage Cell Therapeutics, Inc. Verfahren und zusammensetzungen zur behandlung von netzhauterkrankungen und -leiden
KR20240038013A (ko) 2021-07-28 2024-03-22 리니지 셀 테라퓨틱스, 인크. 망막 색소 상피 세포의 확장
WO2024020326A1 (en) * 2022-07-19 2024-01-25 Khufu Therapeutics, Inc. Systems and methods for in vitro and in vivo liver organoid growth and differentiation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004044158A2 (en) * 2002-11-08 2004-05-27 The Johns Hopkins University Human embryonic stem cell cultures, and compositions and methods for growing same

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523226A (en) * 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
WO1997038090A1 (en) * 1996-04-09 1997-10-16 Board Of The Trustees Of Southern Illinois University A cultural medium for maintaining neural cells in ambient atmosphere
AU5734998A (en) 1997-01-10 1998-08-03 Life Technologies, Inc. Embryonic stem cell serum replacement
YU49899A (sh) * 1997-04-04 2002-09-19 Pfizer Products Inc. Nikotinamidni derivati
GB9715584D0 (en) 1997-07-23 1997-10-01 Eisai Co Ltd Compounds
US7455983B2 (en) * 2000-01-11 2008-11-25 Geron Corporation Medium for growing human embryonic stem cells
GB0001930D0 (en) 2000-01-27 2000-03-22 Novartis Ag Organic compounds
CA2403000C (en) * 2000-03-14 2015-06-23 Es Cell International Pte Ltd Embryonic stem cells and neural progenitor cells derived therefrom
JP2004520386A (ja) 2001-01-31 2004-07-08 ファイザー・プロダクツ・インク Ｐｄｅ４アイソザイムの阻害剤として有用なニコチンアミドビアリール誘導体
WO2003029443A1 (en) 2001-09-28 2003-04-10 Es Cell International Pte Ltd Methods of derivation and propagation of undifferentiated human embryonic stem (hes) cells on feeder-free matrices and human feeder layers
MXPA04005010A (es) * 2001-11-26 2005-04-08 Advanced Cell Tech Inc METODO PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS METODOS PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS HUMANOS REPROGRAMADOS Y CELULAS DEL TALLO HUMANAS AUTOLOGAS E ISOGENICAS.
AU2003201745A1 (en) 2002-02-11 2003-09-04 Pfizer Limited Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
US7736892B2 (en) * 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
US20030161818A1 (en) * 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
GB0206309D0 (en) * 2002-03-16 2002-05-01 Axordia Ltd Isolated cells
WO2003104444A1 (en) * 2002-06-05 2003-12-18 Es Cell International Pte Ltd Generation of neural stem cells from undifferentiated human embryonic stem cells
US7267981B2 (en) 2002-10-07 2007-09-11 Technion Research & Development Foundation Ltd. Human foreskin fibroblasts for culturing ES cells
KR100763477B1 (ko) * 2003-03-12 2007-10-04 리라이언스 라이프 사이언시스 프라이빗. 리미티드 사람 배아 줄기세포로부터 최종적으로 분화된 도파민작용성 뉴런의 유도
US7288658B2 (en) 2003-07-15 2007-10-30 Hoffmann-La Roche Inc. Process for preparation of pyridine derivatives
TWI280280B (en) 2003-12-09 2007-05-01 Ind Tech Res Inst Culture system and method for expansion and undifferentiated growth of human embryonic stem cells
WO2005070120A2 (en) * 2004-01-09 2005-08-04 Serologicals Investment Company, Inc. Cell culture media
US20050196864A1 (en) * 2004-02-10 2005-09-08 Goldman Steven A. Induction and high-yield preparative purification of mesencephalic dopaminergic neuronal progenitor cells and dopaminergic neurons from human embryonic stem cells
CN1950498A (zh) * 2004-03-10 2007-04-18 加利福尼亚大学董事会 培养胚胎干细胞的组合物和方法
WO2006070370A2 (en) 2004-12-29 2006-07-06 Hadasit Medical Research Services & Development Limited Stem cells culture systems
KR20160116024A (ko) 2005-06-22 2016-10-06 아스테리아스 바이오세라퓨틱스, 인크. 인간 배아 줄기 세포의 현탁 배양
EP3640326A1 (de) * 2007-04-18 2020-04-22 Hadasit Medical Research Services & Development Limited Aus stammzellen erhaltene retinale pigmentepithelzellen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004044158A2 (en) * 2002-11-08 2004-05-27 The Johns Hopkins University Human embryonic stem cell cultures, and compositions and methods for growing same

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
AMIT M ET AL: "Human feeder layers for human embryonic stem cells", BIOLOGY OF REPRODUCTION, SOCIETY FOR THE STUDY OF REPRODUCTION, CHAMPAIGN, IL, US, vol. 68, 2003, pages 2150 - 2156, XP002978486, ISSN: 0006-3363 *
AMIT, M., SHARIKI, C., MARGULETS, V., ITSKOVITZ-ELDOR, J.: "Feeder layer- and Serum-Free Culture of Human Embryonic Stem Cells", BIOL REPROD, vol. 70, no. 3, 1 January 2004 (2004-01-01), pages 837 - 45, XP002466324 *
ANDREW L LASLETT ET AL: "Characterization and Culture of Human Embryonic Stem Cells", TRENDS IN CARDIOVASCULAR MEDICINE, vol. 13, no. 7, 1 October 2003 (2003-10-01), pages 295 - 301, XP055047594, ISSN: 1050-1738, DOI: 10.1016/S1050-1738(03)00125-7 *
BREWER G J ET AL: "OPTIMIZED SURVIVAL OF HIPPOCAMPAL NEURONS IN B27-SUPPLEMENTED NEUROBASAL, A NEW SERUM-FREE MEDIUM COMBINATION", JOURNAL OF NEUROSCIENCE RESEARCH, WILEY-LISS, US, vol. 35, no. 5, 1 August 1993 (1993-08-01), pages 567 - 576, XP001097842, ISSN: 0360-4012, DOI: 10.1002/JNR.490350513 *
HOUTENBOS ILSE ET AL: "SERUM-FREE GENERATION OF ANTIGEN PRESENTING CELLS FROM ACUTE MYELOID LEUKAEMIC BLASTS FOR ACTIVE SPECIFIC IMMUNISATION", CANCER IMMUNOLOGY AND IMMUNOTHERAPY, SPRINGER-VERLAG, BERLIN, DE, vol. 52, no. 7, 1 July 2003 (2003-07-01), pages 455 - 462, XP009165874, ISSN: 0340-7004, DOI: 10.1007/S00262-003-0389-4 *
LAM AUDREY C ET AL: "Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: Duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice", TRANSFUSION, AMERICAN ASSOCIATION OF BLOOD BANKS, BETHESDA, MD, US, vol. 41, no. 12, 1 December 2001 (2001-12-01), pages 1567 - 1576, XP002369359, ISSN: 0041-1132, DOI: 10.1046/J.1537-2995.2001.41121567.X *
RAO B ET AL: "Culture development for human embryonic stem cell propagation: molecular aspects and challenges", CURRENT OPINION IN BIOTECHNOLOGY, LONDON, GB, vol. 16, no. 5, 1 October 2005 (2005-10-01), pages 568 - 576, XP027676692, ISSN: 0958-1669, [retrieved on 20051001] *
RICHARDS M ET AL: "Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 20, no. 9, 5 August 2002 (2002-08-05), pages 933 - 936, XP002335247, ISSN: 1087-0156 *
S. MOOG: "Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation", BLOOD, vol. 98, no. 4, 15 August 2001 (2001-08-15), pages 1038 - 1046, XP055048230, ISSN: 0006-4971, DOI: 10.1182/blood.V98.4.1038 *
THOENNES S R ET AL: "Differential transcriptional activation of peroxisome proliferator-activated receptor gamma by omega-3 and omega-6 fatty acids in MCF-7 cells", MOLECULAR AND CELLULAR ENDOCRINOLOGY, ELSEVIER IRELAND LTD, IE, vol. 160, no. 1-2, 25 February 2000 (2000-02-25), pages 67 - 73, XP027339563, ISSN: 0303-7207, [retrieved on 20000225] *

Also Published As

Publication number Publication date
EP2410044B1 (de) 2022-06-22
US9005965B2 (en) 2015-04-14
EP2410044A3 (de) 2013-03-13
US20090104695A1 (en) 2009-04-23
EP2410043A2 (de) 2012-01-25
EP1844136A2 (de) 2007-10-17
US20110177594A1 (en) 2011-07-21
EP2410044A2 (de) 2012-01-25
EP1844136B1 (de) 2014-08-27
ES2525684T3 (es) 2014-12-29
WO2006070370A2 (en) 2006-07-06
WO2006070370A3 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
EP2410044A3 (de) Stammzellenkultursysteme
AU2019268194A1 (en) Cell culture system
EP4223769A3 (de) Nuklearer neuprogrammierungsfaktor
EP2896690A3 (de) Verwendung von RNA zur Neuprogrammierung von Körperzellen
MX356756B (es) Células madre pluripotentes en microportadores.
WO2009007852A3 (en) Multipotent/pluripotent cells and methods
GB2432846A (en) Medium and culture of embryonic stem cells
WO2006044204A3 (en) Neuronal progenitors from feeder-free human embryonic stem cell culture
EP3486314A3 (de) Plazentastammzellenpopulationen
WO2009132063A3 (en) Pluripotent cells
WO2008118392A3 (en) Synthetic cell platforms and methods of use thereof
GB2452456A (en) Cell growth medium
GB2454386A (en) Method for stem cell culture and cells derived therefrom
WO2007016366A3 (en) Defined culture conditions of human embryonic stem cells
EP2727998A3 (de) Verfahren zur Aufreinigung von menschlichen embryonalen Stammzellen abgeleiteter pankreatischer Endodermzellen
IL207268A0 (en) Methods of culture systems of preparing feeder cells - free, xeno - free human embryonic stem cells and stem cell cultures prepared using same
WO2006088867A3 (en) Method for expansion of stem cells
GB2446525A (en) Stem cell culture medium and method
WO2007044418A3 (en) Cell culture media, kits and methods of use
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
WO2008129563A3 (en) Human mesenchymal stem cells and preparation thereof
SG196784A1 (en) Stem cell cultures
WO2008063675A3 (en) Endodermal progenitor cells
WO2005094353A3 (en) Methods for production of regulatory t cells and uses thereof
WO2004015077A3 (en) Compositions and methods for neural differentiation of embryonic stem cells

Legal Events

Date Code Title Description
AC Divisional application: reference to earlier application

Ref document number: 1844136

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/0735 20100101ALI20121220BHEP

Ipc: C12N 5/00 20060101AFI20121220BHEP

Ipc: C12N 5/079 20100101ALI20121220BHEP

17P Request for examination filed

Effective date: 20130723

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20140715

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150701